
RELEVIUM
Using digital tools to empower and improve the lives of patients with pancreatic cancer.
Why Pancreatic cancer Matters
Difficult to Diagnose
Pancreatic cancer has one of the lowest survival rates among other cancers because it is difficult to diagnose early. It is often diagnosed in later stages of the disease, once it has already metastasized.
Unresponsive tumor
The tumors from pancreatic cancer don´t respond as well to commonly used cancer therapies as other less harmful types of cancer.
Serious comorbidities
Some of the comorbidities that exist as a result of pancreatic cancer are pain, emaciation, and jaundice, among others.
OUR MISSION:
Fighting Pancreatic Cancer and Empowering Lives.
We aim to contribute to an improved quality of life of pancreatic cancer patients through advanced pain and cachexia management, nutrition, and physical activity interventions.


OUR OBJECTIVES:
-
Introducing an AI-guided multimodal intervention for patients with advanced pancreatic cancer
-
Implement cutting-edge remote monitoring technologies for the intervention: multi-sensor smartwatch, remote ultrasound patch, combined an AI-driven platform for maximum QoL .
-
Enhance evidence on symptom progression for personalized care plans and to create new care pathways.
-
Evaluate the efficacy of personalized care plans on the quality of life of patients.
-
Investigate secondary outcomes: cost-effectiveness, health equity, and stress reduction for patients and their families.
-
Facilitate patient-doctor communication, enabling patients to self-manage their disease.
Our Social Media:
